BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 11033355)

  • 1. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity.
    De Petrocellis L; Bisogno T; Davis JB; Pertwee RG; Di Marzo V
    FEBS Lett; 2000 Oct; 483(1):52-6. PubMed ID: 11033355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
    Bisogno T; Hanus L; De Petrocellis L; Tchilibon S; Ponde DE; Brandi I; Moriello AS; Davis JB; Mechoulam R; Di Marzo V
    Br J Pharmacol; 2001 Oct; 134(4):845-52. PubMed ID: 11606325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands.
    Di Marzo V; Bisogno T; De Petrocellis L; Brandi I; Jefferson RG; Winckler RL; Davis JB; Dasse O; Mahadevan A; Razdan RK; Martin BR
    Biochem Biophys Res Commun; 2001 Feb; 281(2):444-51. PubMed ID: 11181068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism.
    De Petrocellis L; Bisogno T; Maccarrone M; Davis JB; Finazzi-Agro A; Di Marzo V
    J Biol Chem; 2001 Apr; 276(16):12856-63. PubMed ID: 11278420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
    Melck D; Bisogno T; De Petrocellis L; Chuang H; Julius D; Bifulco M; Di Marzo V
    Biochem Biophys Res Commun; 1999 Aug; 262(1):275-84. PubMed ID: 10448105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors.
    Jerman JC; Gray J; Brough SJ; Ooi L; Owen D; Davis JB; Smart D
    Br J Anaesth; 2002 Dec; 89(6):882-7. PubMed ID: 12453933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.
    Di Marzo V; Lastres-Becker I; Bisogno T; De Petrocellis L; Milone A; Davis JB; Fernandez-Ruiz JJ
    Eur J Pharmacol; 2001 May; 420(2-3):123-31. PubMed ID: 11408034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens.
    Ross RA; Gibson TM; Brockie HC; Leslie M; Pashmi G; Craib SJ; Di Marzo V; Pertwee RG
    Br J Pharmacol; 2001 Feb; 132(3):631-40. PubMed ID: 11159715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid.
    Di Marzo V; Griffin G; De Petrocellis L; Brandi I; Bisogno T; Williams W; Grier MC; Kulasegram S; Mahadevan A; Razdan RK; Martin BR
    J Pharmacol Exp Ther; 2002 Mar; 300(3):984-91. PubMed ID: 11861807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel selective and metabolically stable inhibitors of anandamide cellular uptake.
    Ortar G; Ligresti A; De Petrocellis L; Morera E; Di Marzo V
    Biochem Pharmacol; 2003 May; 65(9):1473-81. PubMed ID: 12732359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases.
    Veldhuis WB; van der Stelt M; Wadman MW; van Zadelhoff G; Maccarrone M; Fezza F; Veldink GA; Vliegenthart JF; Bär PR; Nicolay K; Di Marzo V
    J Neurosci; 2003 May; 23(10):4127-33. PubMed ID: 12764100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between synthetic vanilloids and the endogenous cannabinoid system.
    Di Marzo V; Bisogno T; Melck D; Ross R; Brockie H; Stevenson L; Pertwee R; De Petrocellis L
    FEBS Lett; 1998 Oct; 436(3):449-54. PubMed ID: 9801167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid activation of recombinant and endogenous vanilloid receptors.
    Ralevic V; Kendall DA; Jerman JC; Middlemiss DN; Smart D
    Eur J Pharmacol; 2001 Jul; 424(3):211-9. PubMed ID: 11672565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors.
    De Petrocellis L; Davis JB; Di Marzo V
    FEBS Lett; 2001 Oct; 506(3):253-6. PubMed ID: 11602256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons.
    Roberts LA; Christie MJ; Connor M
    Br J Pharmacol; 2002 Oct; 137(4):421-8. PubMed ID: 12359623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temperature-dependent activation of recombinant rat vanilloid VR1 receptors expressed in HEK293 cells by capsaicin and anandamide.
    Sprague J; Harrison C; Rowbotham DJ; Smart D; Lambert DG
    Eur J Pharmacol; 2001 Jul; 423(2-3):121-5. PubMed ID: 11448475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide.
    Vellani V; Mapplebeck S; Moriondo A; Davis JB; McNaughton PA
    J Physiol; 2001 Aug; 534(Pt 3):813-25. PubMed ID: 11483711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation.
    Tognetto M; Amadesi S; Harrison S; Creminon C; Trevisani M; Carreras M; Matera M; Geppetti P; Bianchi A
    J Neurosci; 2001 Feb; 21(4):1104-9. PubMed ID: 11160380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1).
    Smart D; Gunthorpe MJ; Jerman JC; Nasir S; Gray J; Muir AI; Chambers JK; Randall AD; Davis JB
    Br J Pharmacol; 2000 Jan; 129(2):227-30. PubMed ID: 10694225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase.
    De Petrocellis L; Harrison S; Bisogno T; Tognetto M; Brandi I; Smith GD; Creminon C; Davis JB; Geppetti P; Di Marzo V
    J Neurochem; 2001 Jun; 77(6):1660-3. PubMed ID: 11413249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.